Scleroderma News

Radiotherapy poses no significant risks for worsening disease in patients with systemic sclerosis, but entails “variable risk” for both acute and late toxicities, according to data published in The Journal of Rheumatology.

New recommendations from the American College of Rheumatology and the American College of Chest Physicians strongly advise against glucocorticoids for interstitial lung disease in systemic sclerosis.

Former New York Yankees center fielder Bernie Williams is sharing resources for patients with interstitial lung disease as a tribute to his late father, who lost his battle with idiopathic pulmonary fibrosis in 2001.

Intravenous immunoglobulin treatment may benefit skin, musculoskeletal and gastrointestinal manifestations of systemic sclerosis, with low risks for adverse events, according to data published in Seminars in Arthritis and Rheumatism.

“Aggressive” combination therapy for gastroesophageal reflux disease improved survival among patients with systemic sclerosis and interstitial lung disease, according to data published in Arthritis Research & Therapy.

ORLANDO, Fla. — Including multiple specialists to treat the various facets of systemic sclerosis improves outcomes but can have its own challenges, according to a presenter at the 2024 Rheumatology Nurses Society annual conference.

Nearly 1 year ago, I wrote my first editorial about the emergence and excitement surrounding the early experience with CAR T cells — CAR T Cells in Autoimmunity: A Potential Therapy About to Explode.

It has been at least 2 years since the first cohort of patients with lupus underwent chimeric antigen receptor T-cell treatment, and, at least so far, for every one of them, each new dawn represents another day spent in full remission.

Internal organ, heart and kidney involvement, as well as pulmonary arterial hypertension, are “much more” common in cases of systemic sclerosis that develop after age 60 years, according to data published in Clinical Rheumatology.